ref_name,rx_name,control_variant_name,variant_name,ordinal_number,section,fold_cmp,fold,resistance_level,ineffective,cumulative_count,assay,date_added
Wang21c,Etesevimab,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,Bamlanivimab,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,2-15,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,C121,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,5-7,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,2-17,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,2-17,Control,S:138Y,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,4-19,Control,P.1 Spike,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,4-19,Control,S:18F,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,4-19,Control,S:138Y,1,Fig.1a;Figure S2,>,5000,NULL,experimental,1,NULL,2021-03-03
Wang21c,4-18,Control,P.1 Spike,1,Fig.1a;Figure S2,>,1000,NULL,experimental,1,NULL,2021-03-03
